Manjunatha Ramachandra Kini

Title: Manjunatha Ramachandra Kini: Innovator in Peptide Research

Introduction

Manjunatha Ramachandra Kini is a prominent inventor based in Singapore, known for his significant contributions to the field of peptide research. He has been awarded 3 patents for his innovative work, particularly in the areas of vasodilatory and diuretic functions of peptides. His research has implications for treating various heart conditions and regulating blood pressure.

Latest Patents

One of his latest patents is focused on "Peptides with vasodilatory and/or diuretic functions." This invention relates to modifying key amino acid residues in natriuretic peptides to achieve different functions and properties. The invention also includes modified natriuretic peptides and their use for regulating blood pressure-volume and treating heart conditions. Another notable patent is titled "Compositions and methods for inhibiting thrombogenesis." This invention involves a composition comprising isolated peptides, including variants and mutants of a BF01 peptide. The composition can be used to inhibit thrombogenesis and selectively inhibit the intrinsic pathway of blood coagulation.

Career Highlights

Manjunatha Kini is affiliated with the National University of Singapore, where he conducts his research and development in peptide science. His work has garnered attention in the scientific community, contributing to advancements in medical treatments.

Collaborations

He collaborates with notable colleagues, including Wan Chen and Tse Siang Kang, to further enhance the impact of his research in the field.

Conclusion

Manjunatha Ramachandra Kini's innovative work in peptide research has led to significant advancements in medical science, particularly in the treatment of heart conditions. His contributions continue to shape the future of therapeutic applications in this vital area.